Drometrizole trisiloxane
Identification
- Summary
Drometrizole trisiloxane is an UV ray absorbing agent used in sunscreens to protect skin from UV radiation.
- Generic Name
- Drometrizole trisiloxane
- DrugBank Accession Number
- DB11585
- Background
Drometrizole trisiloxane is a photostable UVA and UVB light filter 1,3,4,5,6,9. The compound is a lipophilic benzotriazole derivative marketed as Meroxyl XL by L'Oreal, although sunscreens with drometrizole trisiloxane are currently only approved for use in the EU, Canada, Australia, and Japan, among other countries.
Despite being used elsewhere in the world with relatively few reports of adverse reactions, the FDA continues to cite that the existing scientific record is not sufficient to establish the compound as being generally recognized as safe and effective for over-the-counter sunscreen use 8,10.
- Type
- Small Molecule
- Groups
- Approved
- Structure
- Weight
- Average: 501.849
Monoisotopic: 501.229921733 - Chemical Formula
- C24H39N3O3Si3
- Synonyms
- Silatrizole
- External IDs
- OR 10154
- OR-10154
Pharmacology
- Indication
Drometrizole trisiloxane is used as an active ingredient in various sunscreens for the indication of protecting the skin by absorbing the damaging UV radiation of sunlight 1,3,4,5,6,9,10.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
As an active ingredient in sunscreen products, drometrizole trisiloxane is applied directly onto human skin where it acts as a chemical sunscreen layer between skin and sunlight that also directly absorbs the UV sunlight radiation 1,3,4,5,6,9. Since drometrizole trisiloxane is also considered to have little to no absorption through the skin 1,3,4,5,6,9, little systemic exposure and pharmacokinetics are expected and users can freely wash off and re-apply the compound as necessary.
- Mechanism of action
Ultraviolet radiation is the invisible energy component to sunlight and consists of three wavelength ranges:
(a) UVA is long-range UV radiation between 320-400nm 7. Although not as energetic as UVB, UVA can penetrate deep into the dermis 7. UVA can cause immediate tanning, premature skin aging, and can also play a role in the formation of some skin cancers 7. Approximately 95% of UVA from the sun passes through Earth's ozone layer 7.
(b) UVB is short-wavelength UV radiation between 280-320nm 7. It is capable of penetrating the outer protective layer of the skin and is responsible for delayed tanning, sunburns, and most skin cancers 7. A large amount of UVB is absorbed by the ozone layer, however, as only 5% reaches the Earth's surface 7.
(c) UVC is comprised of wavelengths between 100-280nm and is very energetic 7. It is very dangerous to all forms of life, even when the exposure is short 7. However, UVC radiation is generally filtered out by the ozone layer and never reaches the Earth 7.
Ultimately, the shorter the wavelength, the more harmful the UV radiation - although shorter wavelength UV radiation is less able to penetrate the skin 7.
Subsequently, drometrizole trisiloxane is a broad spectrum lipophilic benzotriazole derivative chemical sunscreen that is capable of absorbing UVA and UVB radiation 1,3,4,5,6. It is also photostable, meaning that it will not degrade in the presence of sunlight, unlike other UV filters like the widely used UVA absorber avobenzone 6. When combined with the UV blocker ecamsule, it has been shown that the two UV blockers elicit a synergistic effect involving an enhanced protective action for the skin against UVA and UVB radiation 1,3,4,5,6. Additionally, drometrizole trisiloxane is usually combined with other active sunscreen agents like titanium dioxide, avobenzone, and others to ensure the combined product covers or protects against as broad a spectrum of UV radiation as possible, considering drometrizole trisiloxane does not absorb against the entire range of UV radiation 6.
And finally, at the molecular level, it is believed that the general structure of various UV blockers like drometrizole trisiloxane as aromatic molecules conjugated with carbonyl groups is capable of absorbing high energy ultraviolet rays and then consequently releasing that energy as less harmful, lower energy rays.
- Absorption
Drometrizole trisiloxane is reported as having little to no absorption through the skin 3,6. At this time, however, studies demonstrate that the components of most commonly used sunscreens are likely absorbed into the skin at least to some extent - although penetration to deeper tissues and the cutaneous circulation remains limited 2. Despite the extensive use of sunscreen products around the world, there have been few reports of adverse effects related to their use 2.
- Volume of distribution
Drometrizole trisiloxane is reported as having little to no absorption through the skin 3,6. The systemic presence of the compound is consequently expected to be minimal.
- Protein binding
Drometrizole trisiloxane is reported as having little to no absorption through the skin 3,6. The systemic presence of the compound is consequently expected to be minimal.
- Metabolism
Drometrizole trisiloxane is reported as having little to no absorption through the skin 3,6. The systemic presence of the compound is consequently expected to be minimal.
- Route of elimination
Drometrizole trisiloxane is reported as having little to no absorption through the skin 3,6. The systemic presence of the compound is consequently expected to be minimal.
- Half-life
Drometrizole trisiloxane is reported as having little to no absorption through the skin 3,6. The systemic presence of the compound is consequently expected to be minimal.
- Clearance
Drometrizole trisiloxane is reported as having little to no absorption through the skin 3,6. The systemic presence of the compound is consequently expected to be minimal.
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Drometrizole trisiloxane is reported as having little to no absorption through the skin, which leads most national health agencies that approve its use in sunscreens (including the EU, Canada, Australia, Japan, and other countries) to consider it safe, given that most of their toxicity studies return little risk of adverse reactions as well 1,3,4,5,6,9.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Mexoryl XL
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 45 SPF High Protection Uva Uvb Cream Drometrizole trisiloxane (3.0 %) + Avobenzone (3.5 %) + Ecamsule (2.0 %) + Octocrylene (10 %) + Titanium dioxide (3.3 %) Cream Topical Laboratoires La Roche Posay Canada 2008-04-16 2016-08-31 Canada 60 SPF Stick Protection Ciblee Uva Uvb Anthelios XL Drometrizole trisiloxane (2.00 %) + Avobenzone (3.00 %) + Octocrylene (10.00 %) + Titanium dioxide (6.25 %) Stick Topical Laboratoires La Roche Posay Canada 2007-04-12 Not applicable Canada Anthelios Age Correct Drometrizole trisiloxane (1.3 % w/w) + Avobenzone (2.3 % w/w) + Bemotrizinol (3.8 % w/w) + Ecamsule (1 % w/w) + Ensulizole (3.5 % w/w) + Octisalate (5 % w/w) Cream Topical Laboratoires La Roche Posay Canada Not applicable Not applicable Canada Anthelios Dermo-kids Drometrizole trisiloxane (4.5 % w/w) + Avobenzone (3 % w/w) + Ecamsule (1.5 % w/w) + Octisalate (5 % w/w) + Octocrylene (2.5 % w/w) + Titanium dioxide (5.85 % w/w) Lotion Topical Laboratoires La Roche Posay Canada 2015-05-04 Not applicable Canada Anthelios Dermo-kids 50+ Drometrizole trisiloxane (4 % w/w) + Avobenzone (5 % w/w) + Bemotrizinol (6 % w/w) + Ecamsule (0.5 % w/w) + Homosalate (10 % w/w) + Octisalate (5 % w/w) + Titanium dioxide (2.5 % w/w) Cream Topical Laboratoires La Roche Posay Canada Not applicable Not applicable Canada Anthelios SPF 45 Drometrizole trisiloxane (0.5 % w/w) + Avobenzone (3.0 % w/w) + Bemotrizinol (0.5 % w/w) + Ecamsule (1.0 % w/w) + Octisalate (5.0 % w/w) + Octocrylene (5.0 % w/w) + Titanium dioxide (4.7 % w/w) Lotion Topical Laboratoires La Roche Posay Canada 2010-05-04 2015-08-07 Canada Anthelios Spray SPF 45 Drometrizole trisiloxane (1.5 % w/w) + Avobenzone (4.0 % w/w) + Bemotrizinol (3.0 % w/w) + Ecamsule (1.0 % w/w) + Octisalate (5.0 % w/w) + Octocrylene (3.5 % w/w) + Titanium dioxide (2.6 % w/w) Spray Topical Laboratoires La Roche Posay Canada 2010-05-04 2016-06-30 Canada Anthelios XL Cream SPF 60 Drometrizole trisiloxane (3.00 %) + Avobenzone (3.50 %) + Ecamsule (3.00 %) + Octocrylene (10.00 %) + Titanium dioxide (4.15 %) Cream Topical Laboratoires La Roche Posay Canada 2007-04-12 2017-11-30 Canada Anthelios XL Melt-IN Cream Drometrizole trisiloxane (3 % w/w) + Avobenzone (4 % w/w) + Bemotrizinol (5 % w/w) + Ecamsule (0.5 % w/w) + Octisalate (5 % w/w) + Octocrylene (7 % w/w) + Titanium dioxide (2.5 % w/w) Cream Topical Laboratoires La Roche Posay Canada 2019-06-05 2021-08-24 Canada Anthelios XL Stick Drometrizole trisiloxane (3 % w/w) + Avobenzone (2.5 % w/w) + Octisalate (5 % w/w) + Octocrylene (2.5 % w/w) + Titanium dioxide (1 % w/w) Stick Topical Laboratoires La Roche Posay Canada Not applicable Not applicable Canada
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenyl-1,2,3-triazoles. These are organic compounds containing a 1,2,3-triazole substituted by a phenyl group.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Azoles
- Sub Class
- Triazoles
- Direct Parent
- Phenyl-1,2,3-triazoles
- Alternative Parents
- Siloxanes / Phenylpropanes / Benzotriazoles / Para cresols / Toluenes / Trialkylheterosilanes / Heteroaromatic compounds / Organic metalloid salts / Azacyclic compounds / Organopnictogen compounds show 3 more
- Substituents
- Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Benzotriazole / Heteroaromatic compound / Hydrocarbon derivative / Monocyclic benzene moiety / Organic metalloid salt / Organic nitrogen compound / Organic oxygen compound show 13 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Humans and other mammals
Chemical Identifiers
- UNII
- HC22845I1X
- CAS number
- 155633-54-8
- InChI Key
- HUVYTMDMDZRHBN-UHFFFAOYSA-N
- InChI
- InChI=1S/C24H39N3O3Si3/c1-18-14-20(15-19(2)17-33(9,29-31(3,4)5)30-32(6,7)8)24(28)23(16-18)27-25-21-12-10-11-13-22(21)26-27/h10-14,16,19,28H,15,17H2,1-9H3
- IUPAC Name
- 2-(2H-1,2,3-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-(2,2,4,6,6-pentamethyl-3,5-dioxa-2,4,6-trisilaheptan-4-yl)propyl]phenol
- SMILES
- CC(CC1=C(O)C(=CC(C)=C1)N1N=C2C=CC=CC2=N1)C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C
References
- General References
- Gonzalez S, Fernandez-Lorente M, Gilaberte-Calzada Y: The latest on skin photoprotection. Clin Dermatol. 2008 Nov-Dec;26(6):614-26. doi: 10.1016/j.clindermatol.2007.09.010. [Article]
- Benson HA: Assessment and clinical implications of absorption of sunscreens across skin. Am J Clin Dermatol. 2000 Jul-Aug;1(4):217-24. [Article]
- Dermascope: The State of Sunscreen Innovation in 2015 [Link]
- Skin Therapy Letter: Update on Sunscreens [Link]
- Current Trends in Photoprotection - A New Generation of Oral Photoprotectors [Link]
- PhaMix: Mexoryl SX/XL Sunscreens [Link]
- Government of Canada: What is ultraviolet radiation? [Link]
- Chemical & Engineering News: After More Than A Decade, FDA Still Won't Allow New Sunscreens [Link]
- Health Canada: Sunscreen Monograph [File]
- FDA Drometrizole Trisiloxane Safety Assessment Denial Letter [File]
- External Links
- ChemSpider
- 8024601
- 1992874
- Wikipedia
- Drometrizole_trisiloxane
- MSDS
- Download (186 KB)
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Melasma 1 2 Completed Treatment Epidermal p53 Expression / Solar Elastosis 1 Not Available Completed Diagnostic Dermatitis, Photocontact 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Spray Topical Cream Topical Lotion Topical Gel Topical Stick Topical Aerosol Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.000703 mg/mL ALOGPS logP 6.5 ALOGPS logP 7.25 Chemaxon logS -5.8 ALOGPS pKa (Strongest Acidic) 9.96 Chemaxon pKa (Strongest Basic) -0.38 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 69.4 Å2 Chemaxon Rotatable Bond Count 9 Chemaxon Refractivity 137.97 m3·mol-1 Chemaxon Polarizability 54.24 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created at April 27, 2016 22:34 / Updated at June 12, 2020 16:53